Trademark: 98131259
Word
KAYTERIX
Status
Pending
Status Code
686
Status Date
Tuesday, March 12, 2024
Serial Number
98131259
Mark Type
4000
Filing Date
Monday, August 14, 2023
Published for Opposition
Tuesday, March 12, 2024

Trademark Owner History
Regeneron Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain

Trademark Events
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2024
Published For Opposition
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Feb 5, 2024
Approved For Pub - Principal Register
Jan 23, 2024
Assigned To Examiner
Sep 12, 2023
New Application Office Supplied Data Entered
Aug 17, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24